对药物敏感和耐药结核病选择新治疗建议的操作考虑

IF 1.9 Q3 INFECTIOUS DISEASES
John W. Wilson , Zelalem Temesgen , James T. Gaensbauer
{"title":"对药物敏感和耐药结核病选择新治疗建议的操作考虑","authors":"John W. Wilson ,&nbsp;Zelalem Temesgen ,&nbsp;James T. Gaensbauer","doi":"10.1016/j.jctube.2025.100536","DOIUrl":null,"url":null,"abstract":"<div><div>A number of management updates recently have been published for both drug-susceptible and drug-resistant tuberculosis (TB), TB in children, and contacts of patients with drug-resistant TB. The operationalization and application of these recommendations, which reflect favorable clinical trial outcomes, may vary significantly for different patient groups and in different settings. Defining the best treatment approach for each patient requires the integration of multiple data points including organism culture growth and corresponding drug susceptibility profiles, specific TB syndrome, concurrent patient co-morbidities and available public health resources. We review several updated TB treatment recommendations and discuss applicable strengths, select limitations and corresponding precautions as they pertain to diverging patient groups, TB syndromes, and public health capacity.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"40 ","pages":"Article 100536"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Operational considerations of select new treatment recommendations for drug-susceptible and drug-resistant tuberculosis\",\"authors\":\"John W. Wilson ,&nbsp;Zelalem Temesgen ,&nbsp;James T. Gaensbauer\",\"doi\":\"10.1016/j.jctube.2025.100536\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>A number of management updates recently have been published for both drug-susceptible and drug-resistant tuberculosis (TB), TB in children, and contacts of patients with drug-resistant TB. The operationalization and application of these recommendations, which reflect favorable clinical trial outcomes, may vary significantly for different patient groups and in different settings. Defining the best treatment approach for each patient requires the integration of multiple data points including organism culture growth and corresponding drug susceptibility profiles, specific TB syndrome, concurrent patient co-morbidities and available public health resources. We review several updated TB treatment recommendations and discuss applicable strengths, select limitations and corresponding precautions as they pertain to diverging patient groups, TB syndromes, and public health capacity.</div></div>\",\"PeriodicalId\":37942,\"journal\":{\"name\":\"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases\",\"volume\":\"40 \",\"pages\":\"Article 100536\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405579425000270\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405579425000270","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

最近发表了一些关于药物敏感和耐药结核病、儿童结核病和耐药结核病患者接触者的最新管理报告。这些建议的操作和应用反映了良好的临床试验结果,对于不同的患者群体和不同的环境可能会有很大的不同。确定每个患者的最佳治疗方法需要整合多个数据点,包括生物体培养生长和相应的药物敏感性概况,特定的结核病综合征,并发的患者合并症和可用的公共卫生资源。我们回顾了一些最新的结核病治疗建议,并讨论了适用的优势,选择了限制和相应的预防措施,因为它们涉及不同的患者群体,结核病综合征和公共卫生能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Operational considerations of select new treatment recommendations for drug-susceptible and drug-resistant tuberculosis
A number of management updates recently have been published for both drug-susceptible and drug-resistant tuberculosis (TB), TB in children, and contacts of patients with drug-resistant TB. The operationalization and application of these recommendations, which reflect favorable clinical trial outcomes, may vary significantly for different patient groups and in different settings. Defining the best treatment approach for each patient requires the integration of multiple data points including organism culture growth and corresponding drug susceptibility profiles, specific TB syndrome, concurrent patient co-morbidities and available public health resources. We review several updated TB treatment recommendations and discuss applicable strengths, select limitations and corresponding precautions as they pertain to diverging patient groups, TB syndromes, and public health capacity.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases Medicine-Pulmonary and Respiratory Medicine
CiteScore
4.00
自引率
5.00%
发文量
44
审稿时长
30 weeks
期刊介绍: Journal of Clinical Tuberculosis and Mycobacterial Diseases aims to provide a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections, including (but not limited to) epidemiology, clinical investigation, transmission, diagnosis, treatment, drug-resistance and public policy, and encourages the submission of clinical studies, thematic reviews and case reports. Journal of Clinical Tuberculosis and Mycobacterial Diseases is an Open Access publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信